Matches in Wikidata for { <http://www.wikidata.org/entity/Q71063287> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q71063287 description "artículu científicu espublizáu n'abril de 1996" @default.
- Q71063287 description "bài báo khoa học" @default.
- Q71063287 description "im April 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71063287 description "scientific article published on 01 April 1996" @default.
- Q71063287 description "wetenschappelijk artikel" @default.
- Q71063287 description "наукова стаття, опублікована у квітні 1996" @default.
- Q71063287 name "A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients" @default.
- Q71063287 name "A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients" @default.
- Q71063287 type Item @default.
- Q71063287 label "A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients" @default.
- Q71063287 label "A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients" @default.
- Q71063287 prefLabel "A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients" @default.
- Q71063287 prefLabel "A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients" @default.
- Q71063287 P1433 Q71063287-BBF7DF67-6D42-4271-95FF-C0223AB4BE7F @default.
- Q71063287 P1476 Q71063287-E1D4A3AB-9612-47DF-ABA6-5CD954C288F8 @default.
- Q71063287 P2093 Q71063287-070C589C-5B49-49A4-B00F-56F8F025662C @default.
- Q71063287 P2093 Q71063287-0B8CAC88-2EDD-450F-B504-C7B7B2B10447 @default.
- Q71063287 P2093 Q71063287-0FC6C341-1B67-46A8-8187-AB6BF55C1C3B @default.
- Q71063287 P2093 Q71063287-11220DEA-D169-4732-A437-57E9C763A1F0 @default.
- Q71063287 P2093 Q71063287-1737CF17-F4A5-4F6E-9CE8-4B221EA8C0AD @default.
- Q71063287 P2093 Q71063287-36E15047-471B-41CB-BC5F-F7D136F743B4 @default.
- Q71063287 P2093 Q71063287-3DFEC419-CA58-411C-9A9B-8DE5765239EF @default.
- Q71063287 P2093 Q71063287-99FF29F3-D67F-4776-AEC6-CED8DD300893 @default.
- Q71063287 P2093 Q71063287-B34DCFC7-AC9B-44DA-A93E-975DA6FF3654 @default.
- Q71063287 P2093 Q71063287-B5C36C7C-BF80-4175-A5F6-11EE2B30121A @default.
- Q71063287 P2093 Q71063287-D3301DEA-21F4-407D-88E5-274EEAEE19E7 @default.
- Q71063287 P2093 Q71063287-FC0EE5E7-8C97-4780-B108-F811E977FAE8 @default.
- Q71063287 P304 Q71063287-231C6CB8-DE29-4110-9494-C96218DC5EB2 @default.
- Q71063287 P31 Q71063287-E3D6A9EB-FEB7-4E76-8D27-4E270C3427C0 @default.
- Q71063287 P407 Q71063287-66BA361B-1B40-455E-BA81-2E68FD233011 @default.
- Q71063287 P433 Q71063287-65B85807-E589-47D7-8BF5-9BA33E0785E8 @default.
- Q71063287 P478 Q71063287-122A8C01-0B16-4B14-B672-C3854CB1D834 @default.
- Q71063287 P577 Q71063287-670A2657-6922-4010-9F21-80EA4E1B581B @default.
- Q71063287 P698 Q71063287-F39125B4-1306-47C7-9A19-2B76C2136871 @default.
- Q71063287 P921 Q71063287-51C8C1B7-805F-49F7-9F21-9850FBDE8784 @default.
- Q71063287 P921 Q71063287-52496E78-2CB5-4E1A-8519-424448E4DA45 @default.
- Q71063287 P921 Q71063287-8A6EEA69-27E0-4939-B4C5-1196FFE021DD @default.
- Q71063287 P698 8623490 @default.
- Q71063287 P1433 Q7834825 @default.
- Q71063287 P1476 "A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients" @default.
- Q71063287 P2093 "Almond PS" @default.
- Q71063287 P2093 "Canafax DM" @default.
- Q71063287 P2093 "Chambers J" @default.
- Q71063287 P2093 "Duderstadt K" @default.
- Q71063287 P2093 "Fryer J" @default.
- Q71063287 P2093 "Granger DK" @default.
- Q71063287 P2093 "Johnson EM" @default.
- Q71063287 P2093 "Leventhal JR" @default.
- Q71063287 P2093 "Matas AJ" @default.
- Q71063287 P2093 "Scarola J" @default.
- Q71063287 P2093 "Sorenson AL" @default.
- Q71063287 P2093 "Zimmerman J" @default.
- Q71063287 P304 "987" @default.
- Q71063287 P31 Q13442814 @default.
- Q71063287 P407 Q1860 @default.
- Q71063287 P433 "2" @default.
- Q71063287 P478 "28" @default.
- Q71063287 P577 "1996-04-01T00:00:00Z" @default.
- Q71063287 P698 "8623490" @default.
- Q71063287 P921 Q269829 @default.
- Q71063287 P921 Q32089 @default.
- Q71063287 P921 Q323936 @default.